𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A placebo-controlled, double-blind trial of ginkgo biloba for antidepressant-induced sexual dysfunction

✍ Scribed by B.-J. Kang; S.-J. Lee; M.-D. Kim; M.-J. Jo

Book ID
119575895
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
120 KB
Volume
12
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A placebo-controlled, double-blind trial
A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction
✍ Byung-Jo Kang; Seung-Jae Lee; Moon-Doo Kim; Man-Je Cho πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 63 KB

The aim of this study was to examine the effect of Ginkgo biloba on antidepressant-induced sexual dysfunction. The Ginkgo biloba (n=19) and the placebo groups (n=18) were divided; each to be administered with Ginkgo biloba and placebo respectively for 2 months by means of a randomized placebo-contro

Triple-blind, placebo-controlled trial o
Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs
✍ David Wheatley πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 53 KB

## Abstract A triple‐blind (investigator, patient, statistician), randomized, placebo‐controlled, trial of __Ginkgo biloba__ 240 mg daily was carried out. Following a 1‐week control, it was given to 24 patients with sexual impairment due to antidepressant drugs. Efficacy analysis was carried out on

Ginkgo biloba for mild to moderate demen
Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial
✍ Rob McCarney; Peter Fisher; Steve Iliffe; Robbert van Haselen; Mark Griffin; Jan πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 108 KB

## Abstract ## Objectives Doubt over the cost‐effectiveness of the cholinesterase inhibitors in dementia has renewed interest in alternative treatments such as Ginkgo biloba. We aimed to determine the effectiveness and the safety profile of Ginkgo biloba for treating early stage dementia in a comm